P
Paxman AB (publ)
OTC:PXMBF
Paxman AB (publ)
OTC:PXMBF
Price:
3.5
USD
Market Cap:
$103.1m
Relative Value
The Relative Value of one PXMBF stock under the Base Case scenario is 9.24 USD. Compared to the current market price of 3.5 USD, Paxman AB (publ) is Undervalued by 62%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
PXMBF
Relative Value
Base Case
9.24
USD
Undervaluation 62%
P
Multiples Across Competitors
PXMBF Competitors Multiples
Paxman AB (publ) Competitors
Paxman AB (publ) Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| SE |
P
|
Paxman AB (publ)
OTC:PXMBF
|
1.2B USD | 4.2 | 249.3 | 30.8 | 72.3 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
195.3B USD | 4.4 | 29.9 | 17.1 | 23.5 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
175.1B USD | 17.4 | 61.4 | 46.6 | 57.3 | |
| US |
|
Stryker Corp
NYSE:SYK
|
146.4B USD | 5.8 | 45 | 22.8 | 27.5 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
123.2B USD | 3.5 | 26.6 | 14.5 | 21.1 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
107.2B USD | 5.3 | 36.8 | 21.6 | 28.9 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
46.5B EUR | 2 | 22 | 12.1 | 17.1 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
50.5B USD | 11.7 | 47.6 | 33.8 | 37.4 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
49.6B USD | 2.2 | 28 | 10.8 | 18.2 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
49B USD | 8.1 | 45.7 | 25.2 | 27.5 | |
| US |
|
Resmed Inc
NYSE:RMD
|
37.1B USD | 6.9 | 24.9 | 17.6 | 19.6 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
